Thomas M. Argentieri

954 total citations
34 papers, 800 citations indexed

About

Thomas M. Argentieri is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Thomas M. Argentieri has authored 34 papers receiving a total of 800 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Cardiology and Cardiovascular Medicine and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Thomas M. Argentieri's work include Ion channel regulation and function (16 papers), Cardiac electrophysiology and arrhythmias (14 papers) and Urinary Bladder and Prostate Research (7 papers). Thomas M. Argentieri is often cited by papers focused on Ion channel regulation and function (16 papers), Cardiac electrophysiology and arrhythmias (14 papers) and Urinary Bladder and Prostate Research (7 papers). Thomas M. Argentieri collaborates with scholars based in United States, Canada and Poland. Thomas M. Argentieri's co-authors include Jeffrey H. Sheldon, N. Wesley Norton, Thomas Colatsky, John A. Butera, Morgan Woods, Walter Spinelli, Joseph J. McArdle, Schuyler Antane, I Vyas and Herbert E. Lowndes and has published in prestigious journals such as Journal of Biological Chemistry, Circulation Research and Brain Research.

In The Last Decade

Thomas M. Argentieri

32 papers receiving 761 citations

Peers

Thomas M. Argentieri
N. Wesley Norton United States
John A. Butera United States
Lene Teuber Denmark
George Chiu United States
Laurie Tota United States
Renan B. Ferreira United States
David L. Saussy United States
Anthony H. Ingall United Kingdom
Elwood Largis United States
N. Wesley Norton United States
Thomas M. Argentieri
Citations per year, relative to Thomas M. Argentieri Thomas M. Argentieri (= 1×) peers N. Wesley Norton

Countries citing papers authored by Thomas M. Argentieri

Since Specialization
Citations

This map shows the geographic impact of Thomas M. Argentieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Argentieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Argentieri more than expected).

Fields of papers citing papers by Thomas M. Argentieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Argentieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Argentieri. The network helps show where Thomas M. Argentieri may publish in the future.

Co-authorship network of co-authors of Thomas M. Argentieri

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Argentieri. A scholar is included among the top collaborators of Thomas M. Argentieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Argentieri. Thomas M. Argentieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Butera, John A., et al.. (2005). Synthesis and bladder smooth muscle relaxing properties of substituted 3-amino-4-aryl-(and aralkyl-)cyclobut-3-ene-1,2-diones. Bioorganic & Medicinal Chemistry Letters. 15(10). 2495–2501. 13 indexed citations
2.
Zhang, Zhihao, Kenneth J. Rhodes, Wayne E. Childers, Thomas M. Argentieri, & Qiang Wang. (2004). “Disinactivation” of N-type Inactivation of Voltage-gated K Channels by an Erbstatin Analogue. Journal of Biological Chemistry. 279(28). 29226–29230. 13 indexed citations
3.
Zhang, Zhihao, et al.. (2003). Inhibitory effects of pimozide on cloned and native voltage-gated potassium channels. Molecular Brain Research. 115(1). 29–38. 12 indexed citations
4.
Woods, Morgan, et al.. (2001). EFFICACY OF THE β3-ADRENERGIC RECEPTOR AGONIST CL-316243 ON EXPERIMENTAL BLADDER HYPERREFLEXIA AND DETRUSOR INSTABILITY IN THE RAT. The Journal of Urology. 166(3). 1142–1147. 89 indexed citations
5.
Butera, John A., Schuyler Antane, Bradford Hirth, et al.. (2001). Synthesis and potassium channel opening activity of substituted 10H-Benzofuro[3,2-b]indole- and 5,10-Dihydro-indeno[1,2-b]indole-1-carboxylic acids. Bioorganic & Medicinal Chemistry Letters. 11(16). 2093–2097. 62 indexed citations
6.
Butera, John A. & Thomas M. Argentieri. (2000). KCO-616. Drugs of the Future. 25(3). 239–239. 5 indexed citations
7.
Babij, Philip, G. Roger Askew, Bart W. Nieuwenhuijsen, et al.. (1998). Inhibition of Cardiac Delayed Rectifier K + Current by Overexpression of the Long-QT Syndrome HERG G628S Mutation in Transgenic Mice. Circulation Research. 83(6). 668–678. 84 indexed citations
8.
Butera, John A. & Thomas M. Argentieri. (1998). Recent approaches to the treatment of urinary incontinence: a survey of patent activity from 1995 to 1998. Expert Opinion on Therapeutic Patents. 8(8). 1017–1035. 4 indexed citations
9.
Sheldon, Jeffrey H. & Thomas M. Argentieri. (1995). Acute administration of 17 beta-estradiol inhibits calcium currents in isolated guinea pig detrusor myocytes.. Journal of Pharmacology and Experimental Therapeutics. 274(2). 723–729. 15 indexed citations
10.
Colatsky, Thomas & Thomas M. Argentieri. (1994). Potassium channel blockers as antiarrhythmic drugs. Drug Development Research. 33(3). 235–249. 41 indexed citations
11.
Argentieri, Thomas M., et al.. (1993). Electrophysiologic Activity and Antiarrhythmic Efficacy of CK-3579, a New Class III Antiarrhythmic Agent With β-Adrenergic Blocking Properties. Journal of Cardiovascular Pharmacology. 21(4). 647–655. 10 indexed citations
12.
Argentieri, Thomas M., et al.. (1992). Characteristics of synaptic transmission in reinnervating rat skeletal muscle. Pflügers Archiv - European Journal of Physiology. 421(2-3). 256–261. 21 indexed citations
13.
Lumma, William C., et al.. (1992). Synthesis, cardiac electrophysiology, and .beta.-blocking activity of novel arylpiperazines with potential as class II/III antiarrhythmic agents. Journal of Medicinal Chemistry. 35(4). 743–750. 16 indexed citations
14.
Argentieri, Thomas M., et al.. (1991). Cellular Electrophysiological Effects of the Class III Antiarrhythmic Agents Sematilide and Clofilium on Rabbit Atrial Tissues. Journal of Cardiovascular Pharmacology. 18(1). 167–167. 24 indexed citations
15.
16.
Sullivan, Mark, et al.. (1990). Electrophysiological specificity of antiarrhythmic drugs: Is it necessary?. Drug Development Research. 19(2). 187–198. 3 indexed citations
17.
Argentieri, Thomas M., et al.. (1989). Antiarrhythmic peptide has no direct cardiac actions. Cellular and Molecular Life Sciences. 45(8). 737–738. 14 indexed citations
18.
Argentieri, Thomas M., et al.. (1987). Synthesis and cardiac electrophysiological activity of 2- and 3-[(substituted phenyl)alkyl]quinuclidines. Structure-activity relationships. Journal of Medicinal Chemistry. 30(12). 2259–2269. 8 indexed citations
19.
Lumma, William C., et al.. (1987). Synthesis and antiarrhythmic activity of novel 3-alkyl-1-[.omega.-[4-[(alkylsulfonyl)amino]phenyl]-.omega.-hydroxyalkyl]-1H-imidazolium salts and related compounds. 2. Journal of Medicinal Chemistry. 30(12). 2303–2309. 11 indexed citations
20.
Lumma, William C., David D. Davey, Thomas M. Argentieri, et al.. (1987). Rational design of 4-[(methylsulfonyl)amino]benzamides as class III antiarrhythmic agents. Journal of Medicinal Chemistry. 30(5). 755–758. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026